Literature DB >> 9003210

Restoration of the mucociliary clearance of the maxillary sinus after endoscopic sinus surgery.

K Ikeda1, T Oshima, M Furukawa, Y Katori, A Shimomura, T Takasaka, S Maruoka.   

Abstract

BACKGROUND: Whether endoscopic sinus surgery (ESS) restores the mucociliary clearance of the maxillary sinus needs further evaluation.
METHODS: We evaluated the mucociliary clearance of the maxillary sinus by using a radionuclide technique in 12 patients with chronic sinusitis (sinusitis group) and in six patients who had undergone ESS 6 to 14 months after the surgery (post-ESS group). The mucosal cilia taken from the maxillary sinus in 12 patients with sinusitis before and after ESS (paired experiments) were examined by light and electron microscopy.
RESULTS: The radionuclide placed endoscopically in the maxillary sinus in eight patients immediately after ESS maintained 81.2 +/- 16.3% of its radioactivity after 30 minutes. This result was consistent with results in four patients with untreated chronic sinusitis in whom the radionuclide had been instilled by antral puncture (86.9% +/- 3.5%). On the other hand, in six patients in the post-ESS group the radionucleotide maintained only 25.9% +/- 11.6% of its radioactivity, demonstrating statistically significant differences from those of both the sinusitis group without ESS (p < 0.005) and the group 4 days after ESS (p < 0.005). The absence of the cilia in the sinusitis condition was recognized in 35.5% +/- 12.1% (n = 12) of the epithelial cells. On the other hand, the absence of cilia was significantly (p < 0.01) reduced to 5.3% +/- 3.7% of the epithelial cells in the post-ESS condition. Electron microscopic observation also revealed abnormal cilia in the sinusitis condition, whereas the mucosal cilia were regularly arranged in the post-ESS condition.
CONCLUSIONS: The mucociliary clearance of the maxillary sinus disturbed by chronic inflammation was restored by ESS, indicating the clinical effectiveness of ESS for the treatment of chronic sinusitis.

Entities:  

Mesh:

Year:  1997        PMID: 9003210     DOI: 10.1016/s0091-6749(97)70299-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  Effects of surgery on the function of maxillary sinus mucosa.

Authors:  E Toskala; M Rautiainen
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-06       Impact factor: 2.503

2.  Tomographic Imaging of Mucociliary Clearance Following Maxillary Sinus Augmentation: A Case Series.

Authors:  Won-Bae Park; Nam-Jun Cho; Philip Kang
Journal:  Medicina (Kaunas)       Date:  2022-05-18       Impact factor: 2.948

3.  Outcomes of sinus surgery in adults with cystic fibrosis.

Authors:  Ayesha N Khalid; Jess Mace; Timothy L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2009-09       Impact factor: 3.497

4.  Role of measurement of nasal mucociliary clearance by saccharine test as a yard stick of success of functional endoscopic sinus surgery.

Authors:  Mangal Singh; Manish Chandra; S C Gupta; Devashish Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-10-12

5.  Outcomes of endoscopic sinus surgery in adult lung transplant patients with cystic fibrosis.

Authors:  Paolo Luparello; Maria S Lazio; Luca Voltolini; Beatrice Borchi; Giovanni Taccetti; Giandomenico Maggiore
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-28       Impact factor: 2.503

6.  The association of Leptospermum honey with cytokine expression in the sinonasal epithelium of chronic rhinosinusitis patients.

Authors:  Jamil Manji; Andrew Thamboo; Vishnu Sunkaraneni; Amrit Singh; Scott Tebbutt; Cathie Garnis; Amin Javer
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-09-07

7.  Influence of chronic sinusitis and nasal polyp on the lower airway of subjects without lower airway diseases.

Authors:  Suh-Young Lee; Soon Ho Yoon; Woo-Jung Song; So-Hee Lee; Hye-Ryun Kang; Sun-Sin Kim; Sang-Heon Cho
Journal:  Allergy Asthma Immunol Res       Date:  2014-03-21       Impact factor: 5.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.